• Most Popular
  • Most Shared

STOCKS NEWS EUROPE-Medigene up, drug gets orphan status

Wed May 20, 2009 3:50am EDT

Stocks

   

Shares in Medigene (MDGGn.DE) rise 5.4 percent, making it the top gainer among German tech stocks .TECDAX after the biotech's drug Endotag has been granted Orphan drug status by the U.S. FDA for treatment of pancreatic cancer. "The move was perhaps in the cards, as the drug has orphan status in the EU, but receiving approval hadn't featured in the company's discussions recently," says a London-based analyst.

"The approval should help with partnership discussions for the drug, which has blockbuster possibilities," the analyst adds.

A Frankfurt-based trader says that as Endotag is one of the company's few drugs that is nearly or already on the market, the news is quiet positive.

For more double click on [ID:nHUGBVWNTa] [ID:nWEA3552]

Reuters Messaging rm://tyler.sitte.thomsonreuters.com@reuters.net


More from Reuters

Photo

Obama will not rush Afghan troop drawdown

OSLO (Reuters) - There will be no "precipitous drawdown" of U.S. forces in Afghanistan and U.S. troops could still be in the country for years to come, President Barack Obama said on Thursday.

» More Top News
A security personnel stands guard near oil pipelines at Tawke oil field near Dahuk, 400 km (245 miles) north of Baghdad May 9, 2009. REUTERS/Azad Lashkari

Now or never for Big Oil

The pressure's on for oil giants looking to secure rare access to cheap Middle East reserves as Iraq gears up to auction off some of the world's largest untapped oilfields.  Full Article 

Energy
A glass of tap water is served at a restaurant in New York June 10, 2009 REUTERS/Shannon Stapleton

G7 glass half empty

Recovering from a punishing global recession has forced the world's richest nations to pay dearly, prompting subdued growth prospects and delayed sighs of relief.   Full Article 

Global markets